Bayer's Amikacin Inhale misses in Phase III for Gram-negative pneumonia

By Chris Lieu | Dec 8, 2017 | 7:02 PM GMT

Bayer AG (Xetra:BAYN) reported data from the double-blind, international Phase III INHALE program in 725 intubated and mechanically-ventilated patients with